mdexam semaglutide reviews MD Exam: Real Facts and Figures 3 Semaglutide Before and After

Australia's medicines regulator issues a safety warning over the potential risk of suicidal thoughts and behaviours when taking Ozempic-style drugs.

Despite the potential clinical benefits of GLP-1RA plus SGLT2i combination therapy in patients with T2DM, several factors may delay this combination to become a common practice soon, such as reimbursement and costs associated with polypharmacy

After adjustment for sex, BMI, hsCRP, and sCD163, semaglutide significantly decreased epigenetic aging: PCGrimAge (-3.1 years, P = 0.007), GrimAge V1 (-1.4 years, P = 0.02), GrimAge V2 (-2.3 years, P = 0.009), PhenoAge (-4.9 years, P = 0.004), and DunedinPACE (-0.09 units, 9 % slower pace, P = 0.01)

As Eli Lilly prepares to ask for regulatory approval of its first oral GLP-1 pill, named orforglipron, it appears to be scaling back ambitions on a second-gen oral GLP-1 called naperiglipron

This specialized nutritional product is designed to support optimum nutrition and help maintain muscle mass in patients on GLP-1/GIP therapies for type 2 diabetes and obesity management